Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009005917 - METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS

Publication Number WO/2009/005917
Publication Date 08.01.2009
International Application No. PCT/US2008/065152
International Filing Date 29.05.2008
IPC
C07K 14/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
115Paramyxoviridae, e.g. parainfluenza virus
12Mumps virus; Measles virus
A61K 39/165 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
155Paramyxoviridae, e.g. parainfluenza virus
165Mumps or measles virus
CPC
A61K 2039/53
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
51comprising whole cells, viruses or DNA/RNA
53DNA (RNA) vaccination
A61K 2039/541
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
54characterised by the route of administration
541Mucosal route
A61K 2039/55555
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
555characterised by a specific combination antigen/adjuvant
55511Organic adjuvants
55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
A61K 39/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
A61K 39/165
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
155Paramyxoviridae, e.g. parainfluenza virus
165Mumps or measles virus
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
Applicants
  • VICAL INCORPORATED [US]/[US] (AllExceptUS)
  • JOHNS HOPKINS UNIVERSITY [US]/[US] (AllExceptUS)
  • VILALTA, Adrian [US]/[US] (UsOnly)
  • JIMENEZ, Gretchen [US]/[US] (UsOnly)
  • GRIFFIN, Diane, E. [US]/[US] (UsOnly)
Inventors
  • VILALTA, Adrian
  • JIMENEZ, Gretchen
  • GRIFFIN, Diane, E.
Agents
  • MCPHERSON, Scott, E.
Priority Data
60/940,67329.05.2007US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS
(FR) PROCÉDÉS DE TRAITEMENT DE LA MALADIE INFECTIEUSE DE LA ROUGEOLE CHEZ LES MAMMIFÈRES
Abstract
(EN)
The invention provides for a measles vaccine utilizing a human codon-optimized polynucleotide encoding a measles virus polypeptide, such as HA or F protein. Optionally, the vaccine is administered with an adjuvant and is especially useful for immunizing an infant mammal.
(FR)
L'invention porte sur un vaccin contre la rougeole utilisant un polynucléotide optimisé par un codon humain codant un polypeptide du virus de la rougeole, tel qu'une protéine HA ou F. Facultativement, le vaccin est administré avec un adjuvant et est particulièrement utile pour immuniser un mammifère nouveau-né.
Also published as
Latest bibliographic data on file with the International Bureau